High-precision CTE measurement of hybrid C/SiC composite for cryogenic space telescopes

This paper presents highly precise measurements of thermal expansion of a "hybrid" carbon-fiber reinforced silicon carbide composite, HB-Cesic\textregistered - a trademark of ECM, in the temperature region of \sim310-10K. Whilst C/SiC composites have been considered to be promising for the mirrors and other structures of space-borne cryogenic telescopes, the anisotropic thermal expansion has been a potential disadvantage of this material. HB-Cesic\textregistered is a newly developed composite using a mixture of different types of chopped, short carbon-fiber, in which one of the important aims of the development was to reduce the anisotropy. The measurements indicate that the anisotropy was much reduced down to 4% as a result of hybridization. The thermal expansion data obtained are presented as functions of temperature using eighth-order polynomials separately for the horizontal (XY-) and vertical (Z-) directions of the fabrication process. The average CTEs and their dispersion (1{\sigma}) in the range 293-10K derived from the data for the XY- and Z-directions were 0.805$\pm$0.003\times10$^{-6}$ K$^{-1}$ and 0.837\pm0.001\times10$^{-6}$ K$^{-1}$, respectively. The absolute accuracy and the reproducibility of the present measurements are suggested to be better than 0.01\times10$^{-6}$ K$^{-1}$ and 0.001\times(10)^{-6} K^{-1}, respectively. The residual anisotropy of the thermal expansion was consistent with our previous speculation regarding carbon-fiber, in which the residual anisotropy tended to lie mainly in the horizontal plane.Comment: Accepted by Cryogeincs. 12 pages, 3 figures, 1 tabll

Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

Background The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings. Methods We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC who underwent radical or partial nephrectomy with curative intent at our institution between 1981 and 2009. Of them, 98 (22.5%) patients received adjuvant interferon-α (IFN-α) after surgery (adjuvant IFN-α group), while 338 (77.5%) did not (control group). The primary endpoint was cancer-specific survival (CSS). Univariate and multivariate analyses were conducted using log-rank tests and Cox proportional hazards models, respectively. Results Fifty-two (11.9%) patients died from RCC with a median follow-up period of 96 months. Preliminary univariate analyses comparing CSS among treatment groups in each TNM setting revealed that CSS in the control group was equal or superior to that in the adjuvant IFN-α group in earlier stages, while the opposite trend was observed in more advanced stages. We evaluated the TNM cutoffs and demonstrated maximized benefit of adjuvant IFN-α in patients with pT2b-3cN0 (P = 0.0240). In multivariate analysis, ôpT3 and pN1-2 were independent predictors for poor CSS in all patients. In the subgroups with ôpT2 disease (n = 123), pN1-2 and no adjuvant treatment were significant poor prognostic factors. Conclusions Adjuvant immunotherapy after nephrectomy may be beneficial in pT2b-3cN0 RCC. Careful consideration is, however, required for interpretation of this observational study because of its selection bias and adverse effects of IFN-α

Foxc Transcription Factors Directly Regulate Dll4 and Hey2 Expression by Interacting with the VEGF-Notch Signaling Pathways in Endothelial Cells

Recent studies have shown that in the developing embryo, arterial and venous identity is established by genetic mechanisms before circulation begins. Vascular endothelial growth factor (VEGF) signaling and its downstream Notch pathway play critical roles in arterial cell fate determination. We have recently shown that Foxc1 and Foxc2, two closely related Fox transcription factors, are essential for arterial cell specification during development by directly inducing the transcription of Delta-like 4 (Dll4), a ligand for Notch receptors. However, the basic mechanisms whereby the VEGF and Notch signaling pathways control transcriptional regulation of arterial-specific genes have yet to be elucidated.In the current study, we examined whether and how Foxc transcription factors are involved in VEGF and Notch signaling in induction of Dll4 as well as the Notch target gene Hey2 in endothelial cells. We found that Foxc1 and Foxc2 directly activate the Hey2 promoter via Foxc binding elements. Significantly, Foxc2 physically and functionally interacts with a Notch transcriptional activation complex containing Su(H) and Notch intracellular domain to induce Hey2 promoter activity. Moreover, activation of the Dll4 and Hey2 promoters is induced by VEGF in conjunction with either Foxc1 or Foxc2 more than by either component alone. VEGF-activated PI3K and ERK intracellular pathways modulate the transcriptional activity of Foxc proteins in Dll4 and Hey2 induction.Our new findings demonstrate that Foxc transcriptional factors interact with VEGF and Notch signaling to regulate arterial gene expression in multiple steps of the VEGF-Dll4-Notch-Hey2 signaling pathway

Determination of astrophysical 12N(p,g)13O reaction rate from the 2H(12N, 13O)n reaction and its astrophysical implications

The evolution of massive stars with very low-metallicities depends critically on the amount of CNO nuclides which they produce. The $^{12}$N($p$,\,$\gamma$)$^{13}$O reaction is an important branching point in the rap-processes, which are believed to be alternative paths to the slow 3$\alpha$ process for producing CNO seed nuclei and thus could change the fate of massive stars. In the present work, the angular distribution of the $^2$H($^{12}$N,\,$^{13}$O)$n$ proton transfer reaction at $E_{\mathrm{c.m.}}$ = 8.4 MeV has been measured for the first time. Based on the Johnson-Soper approach, the square of the asymptotic normalization coefficient (ANC) for the virtual decay of $^{13}$O$_\mathrm{g.s.}$ $\rightarrow$ $^{12}$N + $p$ was extracted to be 3.92 $\pm$ 1.47 fm$^{-1}$ from the measured angular distribution and utilized to compute the direct component in the $^{12}$N($p$,\,$\gamma$)$^{13}$O reaction. The direct astrophysical S-factor at zero energy was then found to be 0.39 $\pm$ 0.15 keV b. By considering the direct capture into the ground state of $^{13}$O, the resonant capture via the first excited state of $^{13}$O and their interference, we determined the total astrophysical S-factors and rates of the $^{12}$N($p$,\,$\gamma$)$^{13}$O reaction. The new rate is two orders of magnitude slower than that from the REACLIB compilation. Our reaction network calculations with the present rate imply that $^{12}$N($p,\,\gamma$)$^{13}$O will only compete successfully with the $\beta^+$ decay of $^{12}$N at higher ($\sim$two orders of magnitude) densities than initially predicted.Comment: 8 figures, 2 tables, Submitted to Physical Review